ClinicalTrials.Veeva

Menu

The Impact of Infectious Disease on QT Segment

H

HaEmek Medical Center, Israel

Status

Completed

Conditions

Cardiomyopathy, Secondary
Pneumonia
Sepsis

Treatments

Device: ekocardiogram test

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Sepsis related to the development of cardiac complications. However, the investigators understanding regarding this condition remains incomplete. Possible explanations raised include coronary perfusion decrease, activation of the coagulation system and release of inflammatory mediators, including endotoxins, cytokines and others.

In this study the investigators wanted to examine the impact of any infectious disease, (not necessarily Pneumonia), on the QT interval in patients hospitalized for acute infectious disease.

Enrollment

169 patients

Sex

All

Ages

18 to 120 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Internal ward hospitalized patient, due to illness which its etiology is bacterial, fungal or viral

Exclusion criteria

  • Can not technically perform reliably ECG (amputated legs, lack of cooperation, etc.)
  • Subject with permanent pacemaker

Trial design

169 participants in 1 patient group

Patients admitted to an internal medicine department due to an
Treatment:
Device: ekocardiogram test

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems